argenx Statistics
NASDAQ: ARGXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
928.44-2.08 (-0.22%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
argenx by the numbers
argenx has a market capitalization of $57.74 billion based on 62.19M shares outstanding. Its trailing P/E ratio is 35.4, above the 5-company peer median of 32.4, and its forward P/E is 26.7. The stock trades 3.0% below its 50-day average and 9.0% above its 200-day average.
Average daily trading volume is 283.80K shares, or about $263.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ARGX valuation vs. peer median
| Metric | ARGX | Peer median | Difference |
|---|---|---|---|
| Market cap | $57.74B | $19.26B | +200% |
| P/E (TTM) | 35.4 | 32.4 | +9% |
| Forward P/E | 26.7 | 13.4 | +99% |
| Avg. volume | 283.80K | 2.03M | -86% |
Peer median across 8 companies: RVMD, MRNA, BIIB, BNTX, NBIX, EXEL, HALO, TECH.
Valuation
- Market cap
- $57.74B
- P/E (TTM)
- 35.38
- Forward P/E
- 26.74
- EPS (TTM)
- $26.24
- Shares outstanding
- 62.19M
Price and trading
- Previous close
- 930.52
- Open
- 932.08
- Day range
- 921.82 – 942.42
- 52-week range
- 661.85 – 1,072.75
- 52-week change
- +16.44%
- 50-day moving average
- 957.44
- 200-day moving average
- 851.87
- Beta
- —
- Volume
- 258.33K
- Average volume
- 283.80K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 22, 2026
Additional statistics
- Market Cap
- 57.74B
- Pe
- 35.38
- Forward Pe
- 26.74
- Eps
- 26.24
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 1,072.75
- Week52 Low
- 661.85
- Avg Volume
- 283.80K
- Shares Outstanding
- 62.19M
- Ma50
- 957.44
- Ma200
- 851.87
- Earnings Date
- Oct 22, 2026
- Pct From52w High
- -13.45%
- Pct From52w Low
- 40.28%